Pomari, Elena
Voronin, Denis
Alvarez-Martinez, Miriam J.
Arsuaga, Marta
Bottieau, Emmanuel
Luzón-García, María Pilar
Nickel, Beatrice
Rubio, Jose Miguel
Salas-Coronas, Joaquín
Salvador, Fernando
Soriano-Pérez, Manuel Jesús
Sulleiro, Elena
Goterris, Lidia
Van Esbroeck, Marjan
van Hellemond, Jaap J.
Wammes, Linda J.
Zammarchi, Lorenzo
Lavezzari, Denise
Degani, Monica
Tais, Stefano
Held, Jana
Gobbi, Federico
Tamarozzi, Francesca
Funding for this research was provided by:
European Society of Clinical Microbiology and Infectious Diseases (Individual reserach grant to EP)
Ministero della Salute (Fondi “Ricerca Corrente” - L2 to IRCCS Sacro Cuore Don Calabria Hospital, Negrar)
Division of Intramural Research (DIR) of NIAID/NIH USA (to DV)
Article History
Received: 26 November 2024
Accepted: 12 February 2025
First Online: 10 March 2025
Declarations
:
: The study was registered in ClinicalTrials.gov; registration code: NCT06311344. Ethical approval was granted by the ethics committee of IRCCS Sacro Cuore Don Calabria Hospital (Negrar, Verona, Italy; Ethics Committee of Verona and Rovigo provinces Prot n.21711 of 12/04/2021) and of participating centres (Supplementary Text S1). All samples were from patients who consented in writing to the to the storage and use for research purposes of their biological samples.
: The authors declare no competing interests.
: Not applicable.